JP2013534911A5 - - Google Patents

Download PDF

Info

Publication number
JP2013534911A5
JP2013534911A5 JP2013512927A JP2013512927A JP2013534911A5 JP 2013534911 A5 JP2013534911 A5 JP 2013534911A5 JP 2013512927 A JP2013512927 A JP 2013512927A JP 2013512927 A JP2013512927 A JP 2013512927A JP 2013534911 A5 JP2013534911 A5 JP 2013534911A5
Authority
JP
Japan
Prior art keywords
pyrrolidine
compound
formula
radioactive tracer
och
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013512927A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013534911A (ja
JP5851493B2 (ja
Filing date
Publication date
Priority claimed from EP10164663A external-priority patent/EP2394668A1/en
Application filed filed Critical
Publication of JP2013534911A publication Critical patent/JP2013534911A/ja
Publication of JP2013534911A5 publication Critical patent/JP2013534911A5/ja
Application granted granted Critical
Publication of JP5851493B2 publication Critical patent/JP5851493B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013512927A 2010-06-01 2011-06-01 原発性高アルドステロン症の両側性状態と片側性状態との鑑別診断のためのpet放射性医薬 Expired - Fee Related JP5851493B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10164663.6 2010-06-01
EP10164663A EP2394668A1 (en) 2010-06-01 2010-06-01 PET radiopharmaceuticals for differential diagnosis between bilateral and unilateral conditions of primary hyperaldosteronism
PCT/EP2011/059135 WO2011151411A1 (en) 2010-06-01 2011-06-01 Pet radiopharmaceuticals for differential diagnosis between bilateral and unilateral conditions of primary hyperaldosteronism

Publications (3)

Publication Number Publication Date
JP2013534911A JP2013534911A (ja) 2013-09-09
JP2013534911A5 true JP2013534911A5 (enExample) 2014-09-04
JP5851493B2 JP5851493B2 (ja) 2016-02-03

Family

ID=42668720

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013512927A Expired - Fee Related JP5851493B2 (ja) 2010-06-01 2011-06-01 原発性高アルドステロン症の両側性状態と片側性状態との鑑別診断のためのpet放射性医薬

Country Status (4)

Country Link
US (1) US20130089502A1 (enExample)
EP (2) EP2394668A1 (enExample)
JP (1) JP5851493B2 (enExample)
WO (1) WO2011151411A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013151876A1 (en) * 2012-04-04 2013-10-10 Merck Sharp & Dohme Corp. Aldosterone synthase inhibitors
JP6048958B2 (ja) 2012-12-27 2016-12-21 日本メジフィジックス株式会社 副腎疾患の画像診断剤
JP2015193545A (ja) * 2014-03-31 2015-11-05 国立大学法人京都大学 2−(3−ピリジニル)−1h−ベンズイミダゾール誘導体化合物、これを含む放射性医薬
US10189815B2 (en) 2014-06-26 2019-01-29 Nihon Medi-Physics Co., Ltd. 2-(3-pyridinyl)-1H-benzimidazole derivative compound and medicine containing same
CA3026617A1 (en) 2016-06-10 2017-12-14 Nihon Medi-Physics Co., Ltd. Non-invasive diagnostic imaging agent for heart disease
EP3357910A1 (en) * 2017-02-02 2018-08-08 Julius-Maximilians-Universität Würzburg Compound for in vivo diagnosis of a dysfunction of adrenal glands
EP3733661B1 (en) 2017-12-28 2023-03-15 Nihon Medi-Physics Co., Ltd 2-[5-(imidazole-1-ylmethyl)pyridine-3-yl]benzimidazole derivative compound, and medicine including same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006092430A1 (de) * 2005-03-03 2006-09-08 Universität des Saarlandes Selektive hemmstoffe humaner corticoidsynthasen
BRPI0711481A8 (pt) * 2006-05-02 2017-11-28 Univ Michigan Regents derivados radiomarcados de dihidrotetrabenzeno e seu uso como agente de imagens
ES2663351T3 (es) * 2009-11-17 2018-04-12 Novartis Ag Derivados de aril-piridina como inhibidores de la aldosterona sintasa

Similar Documents

Publication Publication Date Title
MY170520A (en) Method of synthesizing thyroid hormone analogs and polymorphs thereof
RU2014110400A (ru) Способ и промежуточные соединения для получения макролактамов
WO2016058467A1 (zh) 磷酸泰地唑胺的制备方法
JP2015227339A5 (enExample)
NZ600791A (en) Solid phase extraction purification technique
RU2020114951A (ru) Термопластичныe полиоксазолидоны из диизоцианатов и производных диглицидилового эфира 2-фенил-1,3-пропандиола
CN105669760A (zh) 一种有机磷杂菲衍生物及其制备方法与应用
JP2012506440A5 (enExample)
CN108129515A (zh) 一种双亚磷酸酯的合成方法
CN104447755B (zh) 一种六氢吡咯[2,3-b]吲哚羧酸酯化合物及其合成方法
JP5851493B2 (ja) 原発性高アルドステロン症の両側性状態と片側性状態との鑑別診断のためのpet放射性医薬
RU2018104555A (ru) Новое соединение, специфически связывающееся с рецептором ampa
CN104277042A (zh) 一种咪唑并吡啶衍生物的制备方法
JP2009137961A5 (enExample)
Pang et al. Halogenations of substituted 2-alkylquinoline with iodine and halide exchange with AgF 2
CN104926868A (zh) 一种制备吲哚膦酸酯衍生物的方法
JP6085884B2 (ja) ビナフトール骨格を有するビスアミノイミン配位子及び触媒
JP2014009330A5 (enExample)
JP2016516809A5 (enExample)
JP2016533390A (ja) 放射ヨウ素標識された3−フルオロプロピル−NOR−β−CITの調製
RU2014131118A (ru) Получение циклокарбонат-функционализованных соединений
RU2015135184A (ru) Способ получения соединения пиридазинона и промежуточных продуктов для его получения
JP2014132089A5 (enExample)
CN108069977A (zh) 一种氟烷基取代吡咯[1,2-a]吲哚的合成方法
CN104804039A (zh) 有机磷系阻燃剂代谢物的合成方法